NurExone Biologic, Inc. is a pharmaceutical company, which engages in the development and commercialization of biological extracellular vesicles-based technology drug platforms. The firm is engaged in developing a platform for biologically guided exosome-based therapies to be delivered, minimally invasive, to patients who have suffered central nervous system injuries. The Company’s first product, ExoPTEN for acute spinal cord injury, uses exosomes loaded with a specific and proprietary sIRNA sequence as the active pharmaceutical ingredient. Its ExoTherapy is a proprietary platform for developing exosome-based therapies. The NurExone platform technology is expected to offer solutions to drug companies interested in minimally invasive targeted drug delivery for other indications.
Follow-Up Questions
Quelle est la performance du prix de l'action NRXBF ?
Le prix actuel de NRXBF est de $0.7421, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Nurexone Biologic Inc ?
Nurexone Biologic Inc appartient à l'industrie Biotechnology et le secteur est Health Care
Quelle est la capitalisation boursière de Nurexone Biologic Inc ?
La capitalisation boursière actuelle de Nurexone Biologic Inc est de $60.4M
Est-ce que Nurexone Biologic Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 5 analystes ont établi des notations d'analystes pour Nurexone Biologic Inc, y compris 3 achat fort, 5 achat, 1 maintien, 0 vente et 3 vente forte
